350 / 1726
Background
Applying the dose to the target volume
Tolerance of normal pelvic structures
Limiting factor
*Example: Treatment schedule outline; cervix cancer. Inst of Oncol Ljubljana (biologically equivalent doses!, LQ model)
Week 5
Week 1 Week 2 Week 3 Week 4
EBRT*
45 Gy
Inhomogeneous!
Week 7
Week 6
40-45 Gy (D90)
BRACHY*